158 related articles for article (PubMed ID: 36578908)
1. Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.
Zheng YZ; Li JY; Ning LW; Xie N
Breast Cancer (Dove Med Press); 2022; 14():475-487. PubMed ID: 36578908
[TBL] [Abstract][Full Text] [Related]
2. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
[TBL] [Abstract][Full Text] [Related]
3. Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy.
Wu Z; Zhang L; Xu S; Lin Y; Yin W; Lu J; Sha R; Sheng X; Zhou L; Lu J
Cancer Cell Int; 2019; 19():78. PubMed ID: 30976202
[TBL] [Abstract][Full Text] [Related]
4. Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant setting.
Wu Z; Zhang L; Peng J; Xu S; Zhou L; Lin Y; Wang Y; Lu J; Yin W; Lu J
Cancer Biol Ther; 2019; 20(6):941-947. PubMed ID: 30866717
[TBL] [Abstract][Full Text] [Related]
5. TRIM58 inactivates p53/p21 to promote chemoresistance via ubiquitination of DDX3 in breast cancer.
Wang J; Yang F; Zhuang J; Huo Q; Li J; Xie N
Int J Biochem Cell Biol; 2022 Feb; 143():106140. PubMed ID: 34954155
[TBL] [Abstract][Full Text] [Related]
6. Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy.
Xu Y; Wang Y; Yuan C; Sheng X; Sha R; Dai H; Zhang S; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
Ther Adv Med Oncol; 2020; 12():1758835920940886. PubMed ID: 32782487
[TBL] [Abstract][Full Text] [Related]
7. TRIM58/cg26157385 methylation is associated with eight prognostic genes in lung squamous cell carcinoma.
Zhang W; Cui Q; Qu W; Ding X; Jiang D; Liu H
Oncol Rep; 2018 Jul; 40(1):206-216. PubMed ID: 29749538
[TBL] [Abstract][Full Text] [Related]
8. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
[TBL] [Abstract][Full Text] [Related]
9. Predictive and prognostic effect of HO-1 expression in breast cancer patients undergoing neoadjuvant chemotherapy.
Tan Q; Qin Q; Huang Z; Lian B; Mo Q; Wei C
Breast Cancer Res Treat; 2022 Jun; 193(2):393-403. PubMed ID: 35304903
[TBL] [Abstract][Full Text] [Related]
10. Grb14 as an independent good prognosis factor for breast cancer patients treated with neoadjuvant chemotherapy.
Huang O; Jiang M; Zhang X; Xie Z; Chen X; Wu J; Liu H; Shen K
Jpn J Clin Oncol; 2013 Nov; 43(11):1064-72. PubMed ID: 24031083
[TBL] [Abstract][Full Text] [Related]
11. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
[TBL] [Abstract][Full Text] [Related]
12. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
Resende U; Cabello C; Ramalho SOB; Zeferino LC
BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of lncRNA LOC100505851 in breast cancer in the neoadjuvant setting.
Sha R; Wu Z; Xu Y; Sheng X; Wang Y; Yuan C; Peng J; Xu S; Zhou L; Lin Y; Yin W; Lu J
Gland Surg; 2021 Jun; 10(6):1899-1909. PubMed ID: 34268074
[TBL] [Abstract][Full Text] [Related]
14. Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer.
Bayarmaa B; Wu Z; Peng J; Wang Y; Xu S; Yan T; Yin W; Lu J; Zhou L
BMC Cancer; 2019 Sep; 19(1):877. PubMed ID: 31488093
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Chen L; Kong X; Huang S; Su Z; Zhu M; Fang Y; Zhang L; Li X; Wang J
Front Immunol; 2022; 13():831848. PubMed ID: 35320931
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
Yang X; Rao J; Yang W; Shui R
Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion.
Liu M; Zhang X; Cai J; Li Y; Luo Q; Wu H; Yang Z; Wang L; Chen D
Oncol Rep; 2018 Sep; 40(3):1251-1260. PubMed ID: 29956813
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication.
Qiu X; Huang Y; Zhou Y; Zheng F
Oncol Rep; 2016 Aug; 36(2):811-8. PubMed ID: 27373520
[TBL] [Abstract][Full Text] [Related]
19. Identification of the molecular function of tripartite motif containing 58 in human lung cancer.
Shi YX
Oncol Lett; 2021 Sep; 22(3):685. PubMed ID: 34434284
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy.
Lin Y; Lin E; Li Y; Chen X; Chen M; Huang J; Guo W; Chen L; Wu L; Zhang X; Zhang W; Jin X; Zhang J; Fu F; Wang C
Pathol Oncol Res; 2022; 28():1610559. PubMed ID: 36405394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
